State of Alaska Department of Revenue cut its stake in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 10.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,367 shares of the medical equipment provider’s stock after selling 2,625 shares during […]
Abiomed (NASDAQ:ABMD – Get Rating) will be posting its quarterly earnings results before the market opens on Thursday, April 28th. Analysts expect Abiomed to post earnings of $1.09 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link. Abiomed (NASDAQ:ABMD – Get Rating) […]
Illinois Municipal Retirement Fund boosted its holdings in shares of Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 56.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 14,031 shares of the medical equipment provider’s stock after purchasing an additional 5,087 shares during the period. Illinois Municipal Retirement […]
Ascent Wealth Partners LLC increased its holdings in shares of Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 3.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,100 shares of the medical equipment provider’s stock after purchasing an additional 303 shares during the period. […]
Wall Street brokerages expect that Abiomed, Inc. (NASDAQ:ABMD – Get Rating) will post $1.09 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Abiomed’s earnings, with the lowest EPS estimate coming in at $1.01 and the highest estimate coming in at $1.28. Abiomed posted earnings […]